Central CO 2 chemosensitivity and CO 2 controller gain independently contribute to daytime P co 2 in young subjects with congenital central hypoventilation syndrome
Journal of Applied Physiology · 01.08.2023 · 135 (2) · 343-351
DOI: 10.1152/japplphysiol.00182.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Physiology, erschienen am 01.08.2023. Verfasst von Plamen Bokov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service de Physiologie Pédiatrique-Centre du Sommeil-CRMR Hypoventilations alvéolaires rares, INSERM NeuroDiderot, Université de Paris-Cité, AP-HP, H…. Hauptthemen laut MEDLINE: Carbon Dioxide, Sleep Apnea, Central. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Altered central CO 2 chemosensitivity is a hallmark of congenital central hypoventilation syndrome (CCHS). Peripheral CO 2 chemosensitivity can be partly assessed by controller gain measurement obtained from tidal breathing recording. In young subjects with CCHS, this study shows that both central and peripheral CO 2 sensitivities independently contribute to daytime Pco 2 . Hypocapnia during nighttime-assisted ventilation is associated with higher peripheral chemosensitivity that is further associated with lesser arterial desaturation at walk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Physiologie Pédiatrique-Centre du Sommeil-CRMR Hypoventilations alvéolaires rares, INSERM NeuroDiderot, Université de Paris-Cité, AP-HP, Hôpital Robert Debré, Paris, France.
- AP-HP, Hôpital de la Pitié-Salpêtrière, Service des Pathologies du Sommeil (Département R3S)-CRMR Hypoventilations centrales congénitales, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbon…
- INSERM NeuroDiderot, Université de Paris-Cité, Paris, France.
ORCID-Profile: Plamen Bokov, Christophe Delclaux
Zitieren
APA
Bokov, P., Dudoignon, B., Patout, M., Matrot, B., Gallego, J., & Delclaux, C. (2023). Central CO 2 chemosensitivity and CO 2 controller gain independently contribute to daytime P co 2 in young subjects with congenital central hypoventilation syndrome. Journal of Applied Physiology, 135(2), 343-351. https://doi.org/10.1152/japplphysiol.00182.2023
Vancouver
Bokov P, Dudoignon B, Patout M, Matrot B, Gallego J, Delclaux C. Central CO 2 chemosensitivity and CO 2 controller gain independently contribute to daytime P co 2 in young subjects with congenital central hypoventilation syndrome. Journal of Applied Physiology. 2023;135(2):343-351. doi:10.1152/japplphysiol.00182.2023
BibTeX
@article{Bokov2023,
author = {Bokov, Plamen and Dudoignon, Benjamin and Patout, Maxime and Matrot, Boris and Gallego, Jorge and Delclaux, Christophe},
title = {Central CO 2 chemosensitivity and CO 2 controller gain independently contribute to daytime P co 2 in young subjects with congenital central hypoventilation syndrome},
journal = {Journal of Applied Physiology},
year = {2023},
volume = {135},
number = {2},
pages = {343--351},
doi = {10.1152/japplphysiol.00182.2023}
}
EUVIMED